Journal
CELL DEATH & DISEASE
Volume 13, Issue 1, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/s41419-022-04506-4
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [82070655, 81472677]
Ask authors/readers for more resources
This study identified HSPC111 as a key gene in promoting pre-metastatic niche formation and colorectal cancer liver metastasis (CRLM). HSPC111 altered the lipid metabolism of cancer-associated fibroblasts (CAFs), leading to the formation of a favorable microenvironment for cancer metastasis. This study suggests that targeting HSPC111 may be a potential therapeutic strategy for preventing CRLM.
Tumor metastasis is a hallmark of cancer. The communication between cancer-derived exosomes and stroma plays an irreplaceable role in facilitating pre-metastatic niche formation and cancer metastasis. However, the mechanisms underlying exosome-mediated pre-metastatic niche formation during colorectal cancer (CRC) liver metastasis remain incompletely understood. Here we identified HSPC111 was the leading upregulated gene in hepatic stellate cells (HSCs) incubated with CRC cell-derived exosomes. In xenograft mouse model, CRC cell-derived exosomal HSPC111 facilitated pre-metastatic niche formation and CRC liver metastases (CRLM). Consistently, CRC patients with liver metastasis had higher level of HSPC111 in serum exosomes, primary tumors and cancer-associated fibroblasts (CAFs) in liver metastasis than those without. Mechanistically, HSPC111 altered lipid metabolism of CAFs by phosphorylating ATP-citrate lyase (ACLY), which upregulated the level of acetyl-CoA. The accumulation of acetyl-CoA further promoted CXCL5 expression and secretion by increasing H3K27 acetylation in CAFs. Moreover, CXCL5-CXCR2 axis reinforced exosomal HSPC111 excretion from CRC cells and promoted liver metastasis. These results uncovered that CRC cell-derived exosomal HSPC111 promotes pre-metastatic niche formation and CRLM via reprogramming lipid metabolism in CAFs, and implicate HSPC111 may be a potential therapeutic target for preventing CRLM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available